Pfizer Reports First-Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St futures rise as Fed rate hike lifts long-standing overhang
- Oil slips as Saudi Arabia offers more crude via Oman
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Pfizer (PFE) Tops Q1 EPS by 15c, Guidance Misses Consensus
May 3, 2022 6:48 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $1.62, $0.15 better than the analyst estimate of $1.47. Revenue for the quarter came in at $25.7 billion versus the consensus estimate of $23.86 billion.
GUIDANCE:
Pfizer sees FY2022 EPS of $6.25-$6.45, versus the consensus of $7.15. Pfizer sees... More
